Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Inflammatory Bowel Diseases"" wg kryterium: Temat


Tytuł:
Evidence for the gut‐skin axis: Common genetic structures in inflammatory bowel disease and psoriasis.
Autorzy:
Guo, Jinyan (AUTHOR)
Luo, Qinghua (AUTHOR)
Li, Chunsheng (AUTHOR)
Liang, Hong (AUTHOR)
Cao, Qiurui (AUTHOR)
Li, Zihao (AUTHOR)
Chen, Guanghua (AUTHOR)
Yu, Xuchao (AUTHOR)
Pokaż więcej
Źródło:
Skin Research & Technology. Feb2024, Vol. 30 Issue 2, p1-12. 12p.
Czasopismo naukowe
Tytuł:
Predictors of disease activity during pregnancy in women with inflammatory bowel disease-a Danish cohort study.
Autorzy:
Vestergaard T; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Julsgaard M; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Clinical Medicine, Center for Molecular Prediction of Inflammatory Bowel Disease, Aalborg University, Copenhagen, Denmark.
Røsok JF; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Vestergaard SV; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
Helmig RB; Department of Obstetrics and Gynaecology, Aarhus University Hospital, Aarhus, Denmark.
Friedman S; Center for Crohn's and Colitis, Brigham and Women's Hospital, Harvard Medical School, Massachusetts, Boston, USA.
Kelsen J; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Feb; Vol. 57 (3), pp. 335-344. Date of Electronic Publication: 2022 Dec 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Inflammatory Bowel Diseases*/diagnosis
Inflammatory Bowel Diseases*/epidemiology
Pregnancy Complications*/diagnosis
Pregnancy Complications*/epidemiology
Pregnancy ; Female ; Humans ; Cohort Studies ; Pregnancy Outcome ; Stillbirth ; Denmark/epidemiology
Czasopismo naukowe
Tytuł:
Editorial: predictors of disease activity during pregnancy in women with inflammatory bowel disease - a Danish cohort study. Authors' reply.
Autorzy:
Vestergaard T; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Kelsen J; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Julsgaard M; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.; Department of Clinical Medicine, Center for Molecular Prediction of Inflammatory Bowel Disease [PREDICT], Aalborg University, Copenhagen, Denmark.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Feb; Vol. 57 (3), pp. 351-352.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Inflammatory Bowel Diseases*/diagnosis
Inflammatory Bowel Diseases*/epidemiology
Pregnancy ; Female ; Humans ; Cohort Studies ; Denmark/epidemiology
Opinia redakcyjna
Tytuł:
Editorial: inflammatory bowel disease and sleep.
Autorzy:
Horsfall E; Department of Gastroenterology, Palmerston North Hospital, Manawatu, New Zealand.
Irwin J; Department of Gastroenterology, Palmerston North Hospital, Manawatu, New Zealand.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Mar; Vol. 57 (5), pp. 573-574.
Typ publikacji:
Letter; Comment
MeSH Terms:
Inflammatory Bowel Diseases*
Humans ; Sleep
Opinia redakcyjna
Tytuł:
Effect of risankizumab on health-related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE, ADVANCE and FORTIFY clinical trials.
Autorzy:
Peyrin-Biroulet L; Department of Gastroenterology, University of Lorraine, CHRU-Nancy, Nancy, France.; University of Lorraine, Inserm, NGERE, Nancy, France.
Ghosh S; APC Microbiome Ireland, University College Cork, Cork, Ireland.
Lee SD; University of Washington, Seattle, Washington, USA.
Lee WJ; AbbVie Inc., North Chicago, Illinois, USA.
Griffith J; AbbVie Inc., North Chicago, Illinois, USA.
Wallace K; AbbVie Inc., North Chicago, Illinois, USA.
Berg S; AbbVie Inc., North Chicago, Illinois, USA.
Liao X; AbbVie Inc., North Chicago, Illinois, USA.
Panes J; Hospital Clínic Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain.
Loftus EV Jr; Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
Louis E; University Hospital CHU of Liège, Liège, Belgium.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Mar; Vol. 57 (5), pp. 496-508. Date of Electronic Publication: 2022 Oct 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Crohn Disease*/drug therapy
Crohn Disease*/chemically induced
Inflammatory Bowel Diseases*/drug therapy
Humans ; Quality of Life ; Antibodies, Monoclonal/adverse effects ; Fatigue/chemically induced ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Letter: tricky reactions to switch back from subcutaneous to intravenous vedolizumab in patients with inflammatory bowel disease.
Autorzy:
Richard N; Department of Gastroenterology, CHU Rouen, Rouen, France.; University of Rouen Normandie, INSERM, ADEN UMR 1073, Nutrition, Inflammation and Microbiota-Gut-Brain Axis, Rouen, France.
Vuitton L; Department of Gastroenterology, Besançon University Hospital, Besançon, France.
Fumery M; Department of Gastroenterology, Amiens University Hospital, Amiens, France.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Mar; Vol. 57 (6), pp. 741-742.
Typ publikacji:
Letter; Comment
MeSH Terms:
Inflammatory Bowel Diseases*/drug therapy
Colitis, Ulcerative*/drug therapy
Humans ; Antibodies, Monoclonal, Humanized/therapeutic use ; Administration, Intravenous ; Gastrointestinal Agents/therapeutic use ; Treatment Outcome
Opinia redakcyjna
Tytuł:
Letter: sleep duration and the incidence of inflammatory bowel disease.
Autorzy:
Chang HC; Library, Chung Shan Medical University Hospital, Taichung, Taiwan.; Evidence-Based Medicine Center, Chung Shan Medical University Hospital, Taichung, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Gau SY; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Mar; Vol. 57 (5), pp. 595-596.
Typ publikacji:
Letter; Comment
MeSH Terms:
Sleep Duration*
Inflammatory Bowel Diseases*/epidemiology
Humans ; Incidence ; Sleep
Opinia redakcyjna
Tytuł:
Editorial: IBD and sleep-authors' reply.
Autorzy:
Yuan S; Department of Big Data in Health Science, School of Public Health and The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Chen J; Department of Big Data in Health Science, School of Public Health and The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Li X; Department of Big Data in Health Science, School of Public Health and The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Mar; Vol. 57 (5), pp. 575-576.
Typ publikacji:
Editorial; Research Support, Non-U.S. Gov't; Comment
MeSH Terms:
Inflammatory Bowel Diseases*
Humans ; Sleep
Raport
Tytuł:
Real world population pharmacokinetic study in children and young adults with inflammatory bowel disease discovers novel blood and stool microbial predictors of vedolizumab clearance.
Autorzy:
Colman RJ; Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Department of Pediatric Gastroenterology and Nutrition, Amsterdam University Medical Centers - Location University of Amsterdam, Emma Children's Hospital, Amsterdam, The Netherlands.
Mizuno T; Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Fukushima K; Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Haslam DB; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.; Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Hyams JS; Division of Digestive Diseases, Hepatology and Nutrition, Connecticut Children's Medical Center, Cincinnati, Ohio, USA.
Boyle B; Division of Gastroenterology, Hepatology and Nutrition, Nationwide Children's Hospital, Columbus, Ohio, USA.
Noe JD; Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Wisconsin, Wauwatosa, Wisconsin, USA.
D'Haens GR; Gastroenterology and Hepatology, Amsterdam University Medical Centers - Location University of Amsterdam, Amsterdam, The Netherlands.
Van Limbergen J; Department of Pediatric Gastroenterology and Nutrition, Amsterdam University Medical Centers - Location University of Amsterdam, Emma Children's Hospital, Amsterdam, The Netherlands.; Tytgat Institute for Liver and Intestinal Research, Amsterdam Gastroenterology Endocrinology Metabolism, University of Amsterdam, Amsterdam, The Netherlands.
Chun K; Esoterix, LabCorp, Burlington, North Carolina, USA.
Yang J; Esoterix, LabCorp, Burlington, North Carolina, USA.
Denson LA; Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Ollberding NJ; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.; Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Vinks AA; Division of Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Minar P; Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Mar; Vol. 57 (5), pp. 524-539. Date of Electronic Publication: 2022 Oct 31.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Inflammatory Bowel Diseases*
Colitis, Ulcerative*/drug therapy
Colitis, Ulcerative*/chemically induced
Humans ; Child ; Young Adult ; Adolescent ; Treatment Outcome ; Gastrointestinal Agents ; Antibodies, Monoclonal, Humanized/adverse effects
Czasopismo naukowe
Tytuł:
Systematic review with meta-analysis: Time to diagnosis and the impact of delayed diagnosis on clinical outcomes in inflammatory bowel disease.
Autorzy:
Jayasooriya N; Department of Gastroenterology, St George's Healthcare NHS Trust, St George's University, London, UK.; Institute of Infection and Immunity, St George's University, London, UK.; School of Public Health, Imperial College London, London, UK.
Baillie S; Department of Gastroenterology, St George's Healthcare NHS Trust, St George's University, London, UK.; Institute of Infection and Immunity, St George's University, London, UK.; School of Public Health, Imperial College London, London, UK.
Blackwell J; Department of Gastroenterology, St George's Healthcare NHS Trust, St George's University, London, UK.; Institute of Infection and Immunity, St George's University, London, UK.; School of Public Health, Imperial College London, London, UK.
Bottle A; School of Public Health, Imperial College London, London, UK.
Petersen I; Department of Primary Care and Population Health, University College London, London, UK.; Department of Clinical Epidemiology, Aarhus University, Aarhus, Denmark.
Creese H; School of Public Health, Imperial College London, London, UK.
Saxena S; School of Public Health, Imperial College London, London, UK.
Pollok RC; Department of Gastroenterology, St George's Healthcare NHS Trust, St George's University, London, UK.; Institute of Infection and Immunity, St George's University, London, UK.; School of Public Health, Imperial College London, London, UK.
Pokaż więcej
Corporate Authors:
POP-IBD study group
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Mar; Vol. 57 (6), pp. 635-652. Date of Electronic Publication: 2023 Jan 10.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Colitis, Ulcerative*/diagnosis
Crohn Disease*/diagnosis
Inflammatory Bowel Diseases*/diagnosis
Humans ; Colectomy ; Delayed Diagnosis
Czasopismo naukowe
Tytuł:
Editorial: achievements and unresolved questions in improving the pharmacokinetics of vedolizumab in adolescents with inflammatory bowel disease.
Autorzy:
Vuijk SA; Department of Paediatric Gastroenterology, Erasmus Medical Center/Sophia Children's Hospital, Rotterdam, The Netherlands.
de Ridder L; Department of Paediatric Gastroenterology, Erasmus Medical Center/Sophia Children's Hospital, Rotterdam, The Netherlands.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Mar; Vol. 57 (5), pp. 565-566.
Typ publikacji:
Editorial; Research Support, Non-U.S. Gov't; Comment
MeSH Terms:
Inflammatory Bowel Diseases*/drug therapy
Humans ; Adolescent ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antibodies, Monoclonal, Humanized/pharmacokinetics
Raport
Tytuł:
Letter: tricky reactions to switch back from subcutaneous to intravenous vedolizumab in inflammatory bowel disease patients-authors' reply.
Autorzy:
Volkers A; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Straatmijer T; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.; Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, the Netherlands.
Duijvestein M; Department of Gastroenterology, Radboud University Medical Center, Nijmegen, the Netherlands.
Löwenberg M; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
van der Meulen A; Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, the Netherlands.
D'Haens G; Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Mar; Vol. 57 (6), pp. 743-744.
Typ publikacji:
Letter; Comment
MeSH Terms:
Inflammatory Bowel Diseases*
Humans ; Antibodies, Monoclonal, Humanized ; Administration, Intravenous
Opinia redakcyjna
Tytuł:
Editorial: achievements and unresolved questions in improving the pharmacokinetics of vedolizumab in adolescents with inflammatory bowel disease-authors' reply.
Autorzy:
Colman RJ; Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Minar P; Division of Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Mar; Vol. 57 (5), pp. 567-568.
Typ publikacji:
Editorial; Research Support, N.I.H., Extramural; Comment
MeSH Terms:
Inflammatory Bowel Diseases*/drug therapy
Adolescent ; Humans ; Antibodies, Monoclonal, Humanized/therapeutic use
Raport
Tytuł:
Systematic review with network meta-analysis: Risk of Herpes zoster with biological therapies and small molecules in inflammatory bowel disease.
Autorzy:
Din S; Edinburgh Inflammatory Bowel Diseases Unit, Western General Hospital, Edinburgh, UK.
Selinger CP; Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.
Black CJ; Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.
Ford AC; Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.; Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Mar; Vol. 57 (6), pp. 666-675. Date of Electronic Publication: 2022 Dec 31.
Typ publikacji:
Journal Article; Meta-Analysis; Review; Systematic Review
MeSH Terms:
Crohn Disease*
Herpes Zoster*/epidemiology
Inflammatory Bowel Diseases*/drug therapy
Janus Kinase Inhibitors*/therapeutic use
Humans ; Biological Therapy ; Network Meta-Analysis
Czasopismo naukowe
Tytuł:
Sleep duration and daytime napping in relation to incident inflammatory bowel disease: a prospective cohort study.
Autorzy:
Yuan S; Department of Big Data in Health Science, School of Public Health and The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.; Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Sun Y; Centre for Global Health, School of Public Health, Zhejiang University School of Medicine, Hangzhou, China.
Tan X; Unit of Functional Pharmacology and neuroscience, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.; Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Geng J; Centre for Global Health, School of Public Health, Zhejiang University School of Medicine, Hangzhou, China.
Sun J; Department of Big Data in Health Science, School of Public Health and The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Chen X; Department of Gastroenterology, The Third Xiangya Hospital, Central South University, Changsha, China.
Yu L; Department of Big Data in Health Science, School of Public Health and The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Wang J; Department of Gastroenterology, The Third Xiangya Hospital, Central South University, Changsha, China.
Zhou X; Department of Big Data in Health Science, School of Public Health and The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Hesketh T; Centre for Global Health, School of Public Health, Zhejiang University School of Medicine, Hangzhou, China.; Institute for Global Health, University College London, London, UK.
Larsson SC; Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.; Unit of Medical Epidemiology, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Chen J; Centre for Global Health, School of Public Health, Zhejiang University School of Medicine, Hangzhou, China.; Department of Gastroenterology, The Third Xiangya Hospital, Central South University, Changsha, China.
Wang X; Department of Gastroenterology, The Third Xiangya Hospital, Central South University, Changsha, China.
Li X; Department of Big Data in Health Science, School of Public Health and The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Liu Z; Center for IBD Research, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Mar; Vol. 57 (5), pp. 475-485. Date of Electronic Publication: 2022 Nov 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Inflammatory Bowel Diseases*/epidemiology
Colitis, Ulcerative*/epidemiology
Crohn Disease*/epidemiology
Humans ; Prospective Studies ; Sleep Duration ; Incidence ; Sleep ; Risk Factors
Czasopismo naukowe
Tytuł:
Editorial: predictors of disease activity during pregnancy in women with inflammatory bowel disease-a Danish cohort study.
Autorzy:
Chowdhury R; Division of Gastroenterology, Hepatology Johns Hopkins University, Baltimore, Maryland, USA.
Kane SV; Division of Gastroenterology, Hepatology Mayo Clinic, Rochester, Minnesota, USA.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Feb; Vol. 57 (3), pp. 349-350.
Typ publikacji:
Editorial
MeSH Terms:
Inflammatory Bowel Diseases*/diagnosis
Pregnancy ; Female ; Humans ; Cohort Studies ; Pregnancy Outcome ; Denmark/epidemiology
Opinia redakcyjna
Tytuł:
A prospective pilot study of a gluten-free diet for primary sclerosing cholangitis and associated colitis.
Autorzy:
Liwinski T; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Center for Affective, Stress and Sleep Disorders (ZASS), University Psychiatric Clinics (UPK) Basel, University of Basel, Basel, Switzerland.
Hübener S; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Henze L; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Hübener P; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Heinemann M; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Tetzlaff M; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Hiller MI; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Jagemann B; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Surabattula R; Institute of Translational Immunology and Research Center for Immunotherapy, University Medical Center, Johannes Gutenberg University, Mainz, Germany.
Leeming D; Research and Development, Nordic Bioscience, Biomarkers and Research A/S, Herlev, Denmark.
Karsdal M; Research and Development, Nordic Bioscience, Biomarkers and Research A/S, Herlev, Denmark.
Monguzzi E; Institute of Translational Immunology and Research Center for Immunotherapy, University Medical Center, Johannes Gutenberg University, Mainz, Germany.
Schachschal G; Department of Interdisciplinary Endoscopy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Rösch T; Department of Interdisciplinary Endoscopy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Bang C; Institute for Clinical Molecular Biology, Christian Albrechts University of Kiel, Kiel, Germany.
Franke A; Institute for Clinical Molecular Biology, Christian Albrechts University of Kiel, Kiel, Germany.
Lohse AW; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Hamburg Center for Translational Immunology, Hamburg, Germany.
Schuppan D; Institute of Translational Immunology and Research Center for Immunotherapy, University Medical Center, Johannes Gutenberg University, Mainz, Germany.; Division of Gastroenterology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Schramm C; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Hamburg Center for Translational Immunology, Hamburg, Germany.; Martin Zeitz Center for Rare Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2023 Jan; Vol. 57 (2), pp. 224-236. Date of Electronic Publication: 2022 Oct 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cholangitis, Sclerosing*/complications
Inflammatory Bowel Diseases*/complications
Colitis*
Humans ; Pilot Projects ; Prospective Studies ; Diet, Gluten-Free ; Inflammation/complications
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies